A199730 logo

BioInfra Co., Ltd. Stock Price

KOSDAQ:A199730 Community·₩19.5b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

A199730 Share Price Performance

₩4,000.00
-1360.00 (-25.37%)
₩4,000.00
-1360.00 (-25.37%)
Price ₩4,000.00

A199730 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Mediocre balance sheet and slightly overvalued.

2 Risks
0 Rewards

BioInfra Co., Ltd. Key Details

₩21.9b

Revenue

₩17.1b

Cost of Revenue

₩4.9b

Gross Profit

₩10.5b

Other Expenses

-₩5.6b

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
-1.16k
22.23%
-25.67%
53.3%
View Full Analysis

About A199730

Founded
2007
Employees
n/a
CEO
Sangdeuk Lee
WebsiteView website
www.bioinfrakorea.co.kr

BioInfra Co., Ltd. operates as a contract research organization for phase 1 clinical trials. The company provides clinical, which undertakes clinical trials for new drug development approval (Phase I-III) and late clinical trials; immunoassay, which performs pharmacokinetic, toxicokinetic, and biomarker analysis of polymer biopharmaceuticals; and testing and inspection, which provides finished drug product quality inspection, comparative dissolution testing, and long-term stability testing. It also specializes in bioequivalence testing of generic drugs, phase 1 clinical trials for new and improved drugs; and sample analysis services for new drug substances. The company was founded in 2007 and is based in Yongin-si, South Korea.

Recent A199730 News & Updates

BioInfra Co., Ltd.'s (KOSDAQ:199730) Share Price Is Matching Sentiment Around Its Revenues

Jan 08
BioInfra Co., Ltd.'s (KOSDAQ:199730) Share Price Is Matching Sentiment Around Its Revenues

Recent updates

No updates